|
Comparison of changes from beginning to end of study in clinical outcomes between treatment and placebo groups |
||||
| Medical outcome variable |
HDM Impermeable bedding, n = 23 |
Placebo bedding, n = 20 |
95% CI of difference |
Significance p |
|
|
||||
| Mean change in 28-day PEF litres/min (sd) |
16.38 (25.62) |
13.68 (43.14) |
-25.15 to 19.75 |
0.81 |
| Mean change in 28-day asthma symptom scores (sd) |
-3.40 (29.50) |
-18.10 (27.80) |
-33.16 to 3.86 |
0.12 |
| Mean change in 28-day rhinitis symptom scores (sd) |
-31.14 (35.79) |
-22.67 (30.70) |
-13.15 to 30.09 |
0.43 |
| Mean change in episodes of monthly night-time waking over 28-day period (sd) |
-0.64 (3.00) |
-0.94 (2.30) |
-2.05 to 1.93 |
0,43 |
| Mean change in 28-day dose of inhaled steroids mcg (sd) |
-1815.91 (3861.45) |
-1039.00 (1881.15) |
-1128.58 to 2682.59 |
0.41 |
| Median non-study GP consultations (range) |
1 (0–5) |
0 (0–5) |
0.26 |
|
| Total number of hospital admissions for asthma |
0 |
0 |
1 |
|
| Total number of courses of oral steroids for asthma |
2 |
2 |
1 |
|
Sheikh et al. BMC Family Practice 2002 3:12 doi:10.1186/1471-2296-3-12 |
||||